What's new

Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

In Europe, biosimilar medicines have captured 7% more of the biologics market over a 5-year period

16 December 2020

Infographic

Open

Growing number of biologic therapies offers future opportunities for biosimilar development

16 December 2020

Infographic

Open

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

5 November 2020

Report

Read more

Educational material on biosimilar medicines, developed by IGBA (International Generic and Biosimilar Medicines Association)

2 November 2020

External Resource

Read more

Second wave pandemic preparedness: procurement principles

24 August 2020

Policy

Open

Policy Roadmap for Medicines Manufacturing Leadership

6 July 2020

Policy

Open

Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns

25 June 2020

Policy

Open

Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney

22 June 2020

Policy

Open

LESSONS LEARNED FROM COVID-19 – POLICY PAPER

22 June 2020

Policy

Open

Questions and answers on regulatory expectations for medicinal products for human use during the COVID-19 pandemic

10 April 2020

External Resource

Open

Subscribe to our newsletter